Genetic Testing, Plasma-Based Genomic Profiling in Solid Tumors
Customize your policy alerts
Sign up for Presbyterian Health Plan Policy 39.0 alerts
Get alerted when Policy 39.0 changes without checking for updates manually.
Monitor payer policy activity
Coverage and prior authorization for plasma-based, cell-free DNA/RNA genomic profiling tests used in solid tumors for Commercial, Medicaid, and Medicare members, subject to Wisconsin LCD L38168, related LCA A57936, and the member’s specific benefit plan.
Code 0487U was changed from investigational and experimental to a covered service and requires prior authorization.
Code 0571U was added as a covered service and requires prior authorization.
Code 0485U was added to the prior authorization configuration because it is listed in the covered Group 1 section of the LCA.
The policy continues to retain code 0409U even though CMS deleted it from LCA Group 1, with prior authorization required.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.